Puma Biotechnology Stock Price Prediction
| PBYI Stock | USD 3.39 0.16 4.95% |
Oversold Vs Overbought
54
Oversold | Overbought |
Quarterly Earnings Growth 2.417 | EPS Estimate Next Quarter 0.11 | EPS Estimate Current Year 0.5 | EPS Estimate Next Year 0.595 | Wall Street Target Price 4.3333 |
Using Puma Biotechnology hype-based prediction, you can estimate the value of Puma Biotechnology from the perspective of Puma Biotechnology response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Puma Biotechnology to buy its stock at a price that has no basis in reality. In that case, they are not buying Puma because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Puma Biotechnology after-hype prediction price | USD 3.21 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Puma |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Puma Biotechnology's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Puma Biotechnology After-Hype Price Prediction Density Analysis
As far as predicting the price of Puma Biotechnology at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Puma Biotechnology or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Puma Biotechnology, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Puma Biotechnology Estimiated After-Hype Price Volatility
In the context of predicting Puma Biotechnology's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Puma Biotechnology's historical news coverage. Puma Biotechnology's after-hype downside and upside margins for the prediction period are 0.16 and 7.53, respectively. We have considered Puma Biotechnology's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Puma Biotechnology is unstable at this time. Analysis and calculation of next after-hype price of Puma Biotechnology is based on 3 months time horizon.
Puma Biotechnology Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Puma Biotechnology is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Puma Biotechnology backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Puma Biotechnology, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.58 | 4.32 | 0.02 | 0.67 | 7 Events / Month | 12 Events / Month | In about 7 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
3.39 | 3.21 | 0.62 |
|
Puma Biotechnology Hype Timeline
Puma Biotechnology is at this time traded for 3.39. The entity has historical hype elasticity of -0.02, and average elasticity to hype of competition of 0.67. Puma is anticipated to decline in value after the next headline, with the price expected to drop to 3.21. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -0.62%, whereas the daily expected return is at this time at 0.58%. The volatility of related hype on Puma Biotechnology is about 374.12%, with the expected price after the next announcement by competition of 4.06. About 15.0% of the company outstanding shares are owned by corporate insiders. The book value of Puma Biotechnology was at this time reported as 1.45. The company has Price/Earnings To Growth (PEG) ratio of 0.03. Puma Biotechnology had not issued any dividends in recent years. Given the investment horizon of 90 days the next anticipated press release will be in about 7 days. Check out Puma Biotechnology Basic Forecasting Models to cross-verify your projections.Puma Biotechnology Related Hype Analysis
Having access to credible news sources related to Puma Biotechnology's direct competition is more important than ever and may enhance your ability to predict Puma Biotechnology's future price movements. Getting to know how Puma Biotechnology's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Puma Biotechnology may potentially react to the hype associated with one of its peers.
Puma Biotechnology Additional Predictive Modules
Most predictive techniques to examine Puma price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Puma using various technical indicators. When you analyze Puma charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Puma Biotechnology Predictive Indicators
The successful prediction of Puma Biotechnology stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Puma Biotechnology, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Puma Biotechnology based on analysis of Puma Biotechnology hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Puma Biotechnology's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Puma Biotechnology's related companies. | 2021 | 2022 | 2023 | 2024 (projected) | Payables Turnover | 5.7 | 8.56 | 9.1 | 9.55 | Days Of Inventory On Hand | 40.73 | 29.98 | 41.23 | 52.69 |
Story Coverage note for Puma Biotechnology
The number of cover stories for Puma Biotechnology depends on current market conditions and Puma Biotechnology's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Puma Biotechnology is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Puma Biotechnology's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Puma Biotechnology Short Properties
Puma Biotechnology's future price predictability will typically decrease when Puma Biotechnology's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Puma Biotechnology often depends not only on the future outlook of the potential Puma Biotechnology's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Puma Biotechnology's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 47.6 M | |
| Cash And Short Term Investments | 95.9 M |
Complementary Tools for Puma Stock analysis
When running Puma Biotechnology's price analysis, check to measure Puma Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Puma Biotechnology is operating at the current time. Most of Puma Biotechnology's value examination focuses on studying past and present price action to predict the probability of Puma Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Puma Biotechnology's price. Additionally, you may evaluate how the addition of Puma Biotechnology to your portfolios can decrease your overall portfolio volatility.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |